Laura Tavanti

590 total citations
21 papers, 334 citations indexed

About

Laura Tavanti is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Laura Tavanti has authored 21 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 3 papers in Molecular Biology. Recurrent topics in Laura Tavanti's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). Laura Tavanti is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (11 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Sarcoidosis and Beryllium Toxicity Research (3 papers). Laura Tavanti collaborates with scholars based in Italy, Switzerland and Netherlands. Laura Tavanti's co-authors include Chiara Romei, Alessandro Celi, Fabio Falaschi, Antonio Palla, Tommaso Neri, Laura Carrozzi, Annalisa De Liperi, Maria Letizia Trincavelli, Ilaria Piano and Chiara Giacomelli and has published in prestigious journals such as PLoS ONE, European Respiratory Journal and Frontiers in Pharmacology.

In The Last Decade

Laura Tavanti

19 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Tavanti Italy 9 217 85 59 35 30 21 334
Jens Lindert United States 7 171 0.8× 129 1.5× 52 0.9× 17 0.5× 76 2.5× 11 436
Manuela Funke Switzerland 10 199 0.9× 119 1.4× 38 0.6× 6 0.2× 23 0.8× 18 315
Ryoji Kato Japan 12 115 0.5× 85 1.0× 21 0.4× 6 0.2× 99 3.3× 31 408
Christine Quast Germany 8 49 0.2× 63 0.7× 18 0.3× 48 1.4× 40 1.3× 24 310
Nathaniel K. Berg United States 8 80 0.4× 200 2.4× 27 0.5× 61 1.7× 30 1.0× 12 417
D. Kyle Hogarth United States 5 142 0.7× 54 0.6× 20 0.3× 17 0.5× 24 0.8× 8 246
P Even Italy 13 233 1.1× 81 1.0× 59 1.0× 6 0.2× 45 1.5× 34 433
Bence Nagy Austria 14 196 0.9× 134 1.6× 58 1.0× 4 0.1× 50 1.7× 36 501
Jone Garay United States 14 123 0.6× 82 1.0× 26 0.4× 7 0.2× 241 8.0× 26 455
Anne‐Marie Lemay Canada 12 91 0.4× 96 1.1× 74 1.3× 5 0.1× 16 0.5× 19 347

Countries citing papers authored by Laura Tavanti

Since Specialization
Citations

This map shows the geographic impact of Laura Tavanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Tavanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Tavanti more than expected).

Fields of papers citing papers by Laura Tavanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Tavanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Tavanti. The network helps show where Laura Tavanti may publish in the future.

Co-authorship network of co-authors of Laura Tavanti

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Tavanti. A scholar is included among the top collaborators of Laura Tavanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Tavanti. Laura Tavanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maio, Sara, Chiara Romei, Annalisa De Liperi, et al.. (2025). COVID-19 pulmonary phenotypes and longitudinal patterns in the first wave of the pandemic. Respiratory Medicine. 237. 107952–107952.
2.
Marzi, Chiara, Sara Colantonio, Laura Tavanti, et al.. (2025). Unlocking the potential of radiomics in identifying fibrosing and inflammatory patterns in interstitial lung disease. La radiologia medica. 130(11). 1797–1807.
3.
Battista, Marco Di, Laura Tavanti, Francesco Pistelli, et al.. (2023). Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects. Inflammopharmacology. 31(5). 2445–2449. 5 indexed citations
4.
Battista, Marco Di, Andrea Delle Sedie, Chiara Romei, et al.. (2023). Lung ultrasound and high-resolution computed tomography quantitative variations during nintedanib treatment for systemic sclerosis-associated interstitial lung disease. Lara D. Veeken. 63(11). 3091–3097. 3 indexed citations
5.
Aimo, Alberto, Giosafat Spitaleri, Dario Nieri, et al.. (2022). Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond. Cardiac failure review. 8. e12–e12. 48 indexed citations
6.
Romei, Chiara, Laura Tavanti, Annalisa De Liperi, et al.. (2020). Automated Computed Tomography analysis in the assessment of Idiopathic Pulmonary Fibrosis severity and progression. European Journal of Radiology. 124. 108852–108852. 41 indexed citations
7.
Vancheri, Carlo, Alfredo Sebastiani, Alberto Pesci, et al.. (2019). Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis. Respiratory Medicine. 156. 78–84. 20 indexed citations
8.
Neri, Tommaso, Laura Tavanti, Stefania Lombardi, et al.. (2019). Endothelial Cell-Derived Extracellular Vesicles as Potential Biomarkers in Chronic Interstitial Lung Diseases.. PubMed. 49(5). 608–610. 6 indexed citations
9.
Giacomelli, Chiara, Simona Daniele, Chiara Romei, et al.. (2018). The A2B Adenosine Receptor Modulates the Epithelial– Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells. Frontiers in Pharmacology. 9. 54–54. 61 indexed citations
10.
Romei, Chiara, Laura Tavanti, Jelle Miedema, et al.. (2018). The use of chest magnetic resonance imaging in interstitial lung disease: a systematic review. European Respiratory Review. 27(150). 180062–180062. 31 indexed citations
11.
Palla, Antonio, Alessandro Celi, Letizia Marconi, et al.. (2015). Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive. Cancer Investigation. 33(4). 142–151. 3 indexed citations
12.
Romei, Chiara, Laura Tavanti, Annalisa De Liperi, et al.. (2015). Idiopathic interstitial pneumonias: do HRCT criteria established by ATS/ERS/JRS/ALAT in 2011 predict disease progression and prognosis?. La radiologia medica. 120(10). 930–940. 29 indexed citations
13.
Novelli, Federica, Tommaso Neri, Laura Tavanti, et al.. (2014). Procoagulant, Tissue Factor-Bearing Microparticles in Bronchoalveolar Lavage of Interstitial Lung Disease Patients: An Observational Study. PLoS ONE. 9(4). e95013–e95013. 44 indexed citations
14.
Novelli, Federica, Laura Tavanti, Ferruccio Aquilini, et al.. (2014). Determinants of the prognosis of idiopathic pulmonary fibrosis.. PubMed. 18(6). 880–6. 8 indexed citations
15.
Desideri, Massimiliano, et al.. (2013). Sleep related respiratory disorders (SRD) in patients with usual interstitial pneumonia (UIP). European Respiratory Journal. 42(Suppl 57). P2372–P2372. 1 indexed citations
16.
Pistelli, Francesco, Ferruccio Aquilini, Laura Tavanti, et al.. (2011). Predictors of smoking cessation within a lung cancer CT screening trial. 38. 4248. 4 indexed citations
17.
Neri, Tommaso, Ilaria Conti, Chiara Cerri, et al.. (2010). Divergent effects of Nitric oxide on airway epithelial cell activation. Biological Research. 43(4). 467–473. 1 indexed citations
18.
Carozzi, Francesca Maria, Simonetta Bisanzi, Patrizia Falini, et al.. (2009). Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis. Lung Cancer. 68(2). 216–221. 10 indexed citations
19.
Petruzzelli, Stefano, Laura Tavanti, E. Fornai, et al.. (2000). Effects of nicotine replacement therapy on markers of oxidative stress in cigarette smokers enrolled in a smoking cessation program. Nicotine & Tobacco Research. 2(4). 345–350. 15 indexed citations
20.
Antonuzzo, Andrea, Luca Galli, Stefano Ricci, et al.. (1998). Gemcitabine monotherapy in the elderly patient with advanced non-small cell lung cancer (NSCLC): preliminary results of a tuscany multicentric phase II study. Lung Cancer. 21. S48–S48. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Lindert Breakdown of academic impact, for papers by Manuela Funke Breakdown of academic impact, for papers by Ryoji Kato Breakdown of academic impact, for papers by Christine Quast Breakdown of academic impact, for papers by Nathaniel K. Berg Breakdown of academic impact, for papers by D. Kyle Hogarth Breakdown of academic impact, for papers by P Even Breakdown of academic impact, for papers by Bence Nagy Breakdown of academic impact, for papers by Jone Garay Breakdown of academic impact, for papers by Anne‐Marie Lemay
Rankless by CCL
2026